Nihon Kohden Corporation (NHNKY)
Nihon Kohden Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Tokyo, TY, JP. The stock last traded at $10.28, up 2.03% on the session, giving a market capitalisation of $3.29B. On trailing twelve-month figures it carries a trailing P/E of 19.42, a net margin of 5.9%. Its beta of 0.38 implies it has historically moved less than the broad market.
Nihon Kohden Corporation specializes in the comprehensive lifecycle of medical electronic equipment, from research and development and manufacturing to sales, repair, and ongoing maintenance. The company operates across a global footprint encompassing Japan, the Americas, Europe, and the wider Asian market, as well as other international regions. Their diverse product portfolio includes advanced physiological measurement devices such as electroencephalographs (EEGs), electrocardiographs (ECGs), evoked potential and electromyogram instruments, and polygraphs tailored for catheterization laboratories. These are often complemented by sophisticated diagnostic information systems, along with essential consumables like recording papers, electrodes, and various catheters, supported by comprehensive maintenance services. The company also delivers complete patient monitoring solutions, which encompass central, bedside, and wireless monitors, remote access software, and associated clinical information systems. These systems utilize critical consumables like specialized electrodes and sensors. Furthermore, Nihon Kohden offers a range of therapeutic devices, including life-saving defibrillators (both manual and automated external defibrillators or AEDs), ventilators, pacemakers, anesthesia machines, and cochlear implants. These are supplied with necessary consumables, such as AED pads and batteries, and accompanying support services. Their offerings extend to other specialized medical apparatus, such as hematology and clinical chemistry analyzers, ultrasound diagnostic units, and equipment designed for research purposes. Crucially, these are supported by specific consumables like test reagents, alongside installation and ongoing maintenance services. Beyond its core medical device operations, the corporation also holds interests in insurance brokerage and technology licensing. Established in 1951, the company maintains its headquarters in Tokyo, Japan.
Nihon Kohden Corporation is most often compared with the following Healthcare names: